Response Genetics, Inc
RGDXQ · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Market Cap | $35 | $12,270 | $38,838 | $37,172 |
| - Cash | $19,459 | $2,222 | $8,149 | $9,041 |
| + Debt | $6,373 | $9,668 | $1,294 | $1,243 |
| Enterprise Value | -$13,051 | $19,716 | $31,984 | $29,373 |
| Revenue | $18,040 | $16,720 | $19,801 | $18,737 |
| % Growth | 7.9% | -15.6% | 5.7% | – |
| Gross Profit | $3,942 | $6,709 | $9,345 | $8,321 |
| % Margin | 21.9% | 40.1% | 47.2% | 44.4% |
| EBITDA | -$19,666 | -$13,008 | -$7,946 | -$7,201 |
| % Margin | -109% | -77.8% | -40.1% | -38.4% |
| Net Income | -$20,184 | -$13,536 | -$7,479 | -$7,373 |
| % Margin | -111.9% | -81% | -37.8% | -39.3% |
| EPS Diluted | -0.52 | -0.35 | -0.22 | -0.28 |
| % Growth | -48.6% | -59.1% | 21.4% | – |
| Operating Cash Flow | -$13,599 | -$14,300 | -$6,489 | -$8,011 |
| Capital Expenditures | -$1,145 | -$104 | -$608 | -$957 |
| Free Cash Flow | -$14,744 | -$14,404 | -$7,097 | -$8,968 |